Gene · 994
Papers2,079
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 2,079
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The prognostic role of FZD6 in esophageal squamous cell carcinoma patients. | Clin Transl Oncol | 2020 | 31748958 | PubTator, text mining | PubMed |
| Combining Free Energy Simulations and NMR Chemical-Shift Perturbation To Identify Transient Cation-π Contacts in Proteins. | J Chem Inf Model | 2020 | 31738549 | PubTator, text mining | PubMed |
| High-content screening in zebrafish identifies perfluorooctanesulfonamide as a potent developmental toxicant. | Environ Pollut | 2020 | 31706782 | PubTator, text mining | PubMed |
| SNHG16 as the miRNA let-7b-5p sponge facilitates the G2/M and epithelial-mesenchymal transition by regulating CDC25B and HMGA2 expression in hepatocellular carcinoma. | J Cell Biochem | 2020 | 31696971 | PubTator, text mining | PubMed |
| Comparison of the different mechanisms of cytotoxicity induced by checkpoint kinase I inhibitors when used as single agents or in combination with DNA damage. | Oncogene | 2020 | 31659257 | PubTator, text mining | PubMed |
| The combination of BET and PARP inhibitors is synergistic in models of cholangiocarcinoma. | Cancer Lett | 2020 | 31605774 | PubTator, text mining | PubMed |
| miR-215-5p is an anticancer gene in multiple myeloma by targeting RUNX1 and deactivating the PI3K/AKT/mTOR pathway. | J Cell Biochem | 2020 | 31498483 | PubTator, text mining | PubMed |
| An integrative sparse boosting analysis of cancer genomic commonality and difference. | Stat Methods Med Res | 2020 | 31282286 | PubTator, text mining | PubMed |
| Overcome cancer drug resistance by targeting epigenetic modifications of centrosome. | Cancer Drug Resist | 2019 | 35582716 | PubTator, text mining | PubMed |
| 5-Acetamido-1-(methoxybenzyl) isatin inhibits tumor cell proliferation, migration, and angiogenesis. | RSC Adv | 2019 | 35539063 | PubTator, text mining | PubMed |
| Screening of differential expressed genes from gene chip and sequencing data and evaluate its prognostic values in males with digestive system neoplasms. | Transl Cancer Res | 2019 | 35116986 | PubTator, text mining | PubMed |
| Transgenic rhesus monkeys carrying the human MCPH1 gene copies show human-like neoteny of brain development. | Natl Sci Rev | 2019 | 34691896 | PubTator, text mining | PubMed |
| CDK Blockade Using AT7519 Suppresses Acute Myeloid Leukemia Cell Survival through the Inhibition of Autophagy and Intensifies the Anti-leukemic Effect of Arsenic Trioxide. | Iran J Pharm Res | 2019 | 32802093 | PubTator, text mining | PubMed |
| Potential Prognostic and Diagnostic Values of CDC6, CDC45, ORC6 and SNHG7 in Colorectal Cancer. | Onco Targets Ther | 2019 | 32021241 | PubTator, text mining | PubMed |
| DNA replication stress: oncogenes in the spotlight. | Genet Mol Biol | 2019 | 31930281 | PubTator, text mining | PubMed |
| From yeast to humans: Understanding the biology of DNA Damage Response (DDR) kinases. | Genet Mol Biol | 2019 | 31930279 | PubTator, text mining | PubMed |
| Transcriptome Analysis of Ochratoxin A-Induced Apoptosis in Differentiated Caco-2 Cells. | Toxins (Basel) | 2019 | 31906179 | PubTator, text mining | PubMed |
| Cyclin-dependent kinase 7 inhibitor THZ1 in cancer therapy. | Chronic Dis Transl Med | 2019 | 31891127 | PubTator, text mining | PubMed |
| Sulforaphene induces apoptosis and inhibits the invasion of esophageal cancer cells through MSK2/CREB/Bcl-2 and cadherin pathway in vivo and in vitro. | Cancer Cell Int | 2019 | 31889894 | PubTator, text mining | PubMed |
| CDK1 and CCNB1 as potential diagnostic markers of rhabdomyosarcoma: validation following bioinformatics analysis. | BMC Med Genomics | 2019 | 31870357 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/994/papers?page=36